                         SEQUENCE LISTING

<110>  LIPOTEC, S.A.
 
<120>  PEPTIDES WHICH INHIBIT ACTIVATED RECEPTORS AND THEIR USE IN 			COSMETIC OR PHARMACEUTICAL COMPOSITIONS 

<130>  PA

<140>  ES P2011-00000
<141>  2011-11-04

<160>  97    

<170>  PatentIn version 3.5

<210>  1
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  1

Phe Met Arg Asp His Ser 
1               5       


<210>  2
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  2

Phe Met Gln Phe His Ser 
1               5       


<210>  3
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  3

Phe Phe Gln Phe His Ser 
1               5       


<210>  4
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  4

Ser Phe Gln Phe His Ser 
1               5       


<210>  5
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  5

Phe Met Trp Phe His Ser 
1               5       


<210>  6
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  6

Ser Met Trp Phe His Ser 
1               5       


<210>  7
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  7

Phe Phe Trp Phe His Ser 
1               5       


<210>  8
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  8

Ser Phe Trp Phe His Ser 
1               5       


<210>  9
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  9

Phe Phe Gln Asp Ile Ser 
1               5       


<210>  10
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  10

Phe Met Trp Asp Ile Ser 
1               5       


<210>  11
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  11

Phe Phe Trp Asp Ile Ser 
1               5       


<210>  12
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  12

Phe Met Arg Phe Ile Ser 
1               5       


<210>  13
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  13

Ser Phe Arg Phe Ile Ser 
1               5       


<210>  14
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  14

Phe Met Gln Phe Ile Ser 
1               5       


<210>  15
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  15

Ser Met Gln Phe Ile Ser 
1               5       


<210>  16
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  16

Phe Phe Gln Phe Ile Ser 
1               5       


<210>  17
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  17

Ser Phe Gln Phe Ile Ser 
1               5       


<210>  18
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  18

Phe Met Trp Phe Ile Ser 
1               5       


<210>  19
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  19

Ser Met Trp Phe Ile Ser 
1               5       


<210>  20
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  20

Phe Phe Trp Phe Ile Ser 
1               5       


<210>  21
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  21

Ser Phe Trp Phe Ile Ser 
1               5       


<210>  22
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  22

Phe Phe Arg Asp His Val 
1               5       


<210>  23
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  23

Phe Phe Trp Asp His Val 
1               5       


<210>  24
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  24

Phe Met Arg Phe His Val 
1               5       


<210>  25
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  25

Phe Phe Arg Phe His Val 
1               5       


<210>  26
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  26

Phe Met Gln Phe His Val 
1               5       


<210>  27
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  27

Ser Met Gln Phe His Val 
1               5       


<210>  28
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  28

Phe Phe Gln Phe His Val 
1               5       


<210>  29
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  29

Phe Met Trp Phe His Val 
1               5       


<210>  30
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  30

Ser Met Trp Phe His Val 
1               5       


<210>  31
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  31

Phe Phe Trp Phe His Val 
1               5       


<210>  32
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  32

Ser Phe Trp Phe His Val 
1               5       


<210>  33
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  33

Phe Phe Arg Asp Ile Val 
1               5       


<210>  34
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  34

Phe Met Gln Asp Ile Val 
1               5       


<210>  35
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  35

Phe Phe Gln Asp Ile Val 
1               5       


<210>  36
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  36

Phe Met Trp Asp Ile Val 
1               5       


<210>  37
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  37

Phe Phe Trp Asp Ile Val 
1               5       


<210>  38
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  38

Phe Met Arg Phe Ile Val 
1               5       


<210>  39
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  39

Ser Met Arg Phe Ile Val 
1               5       


<210>  40
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  40

Phe Phe Arg Phe Ile Val 
1               5       


<210>  41
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  41

Ser Phe Arg Phe Ile Val 
1               5       


<210>  42
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  42

Phe Met Gln Phe Ile Val 
1               5       


<210>  43
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  43

Ser Met Gln Phe Ile Val 
1               5       


<210>  44
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  44

Phe Phe Gln Phe Ile Val 
1               5       


<210>  45
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  45

Ser Phe Gln Phe Ile Val 
1               5       


<210>  46
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  46

Phe Met Trp Phe Ile Val 
1               5       


<210>  47
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  47

Ser Met Trp Phe Ile Val 
1               5       


<210>  48
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  48

Phe Phe Trp Phe Ile Val 
1               5       


<210>  49
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is Nva

<400>  49

Phe Met Asn Trp Ile Xaa 
1               5       


<210>  50
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is Nva

<400>  50

Phe Met Asn Tyr Ile Xaa 
1               5       


<210>  51
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa is Nva

<400>  51

Phe Met Gln Trp Xaa Ile 
1               5       


<210>  52
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa is Nva

<400>  52

Phe Met Asn Tyr Xaa Ile 
1               5       


<210>  53
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa is Nle

<400>  53

Phe Met Gln Trp Xaa Ile 
1               5       


<210>  54
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is Phg

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa is Nle

<400>  54

Phe Met Gln Xaa Xaa Ala 
1               5       


<210>  55
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa is Nle

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is Nle

<400>  55

Phe Met Gln Tyr Xaa Xaa 
1               5       


<210>  56
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is Phg

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa is Nva

<400>  56

Phe Met Gln Xaa Xaa Ala 
1               5       


<210>  57
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa is Nva

<400>  57

Phe Met Gln Trp Xaa Ala 
1               5       


<210>  58
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is Phg

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is Nle

<400>  58

Phe Trp Gln Xaa Ile Xaa 
1               5       


<210>  59
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa is Nle

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is Nle

<400>  59

Phe Trp Gln Tyr Xaa Xaa 
1               5       


<210>  60
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is Cit

<400>  60

Phe Trp Xaa Gln Ile Val 
1               5       


<210>  61
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is Nle

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is Cit

<400>  61

Phe Xaa Xaa Gln Ile Val 
1               5       


<210>  62
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is Nle

<400>  62

Phe Xaa His Asn Ile Val 
1               5       


<210>  63
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is Nva

<400>  63

Phe Xaa His Gln Ile Val 
1               5       


<210>  64
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is Nva

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is Cit

<400>  64

Phe Xaa Xaa Gln Ile Val 
1               5       


<210>  65
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is Nva

<400>  65

Phe Xaa His Asn Ile Val 
1               5       


<210>  66
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is Nva

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is Cit

<400>  66

Phe Xaa Xaa Asn Ile Val 
1               5       


<210>  67
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is Nle

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is Orn

<400>  67

Phe Xaa Xaa Asp Ile Thr 
1               5       


<210>  68
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is Nle

<400>  68

Phe Xaa Lys Asp Ile Val 
1               5       


<210>  69
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is Phg

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is Orn

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa is Cit

<400>  69

Phe Xaa Xaa Asp Xaa Thr 
1               5       


<210>  70
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is Phg

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is Orn

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa is Cit

<400>  70

Phe Xaa Xaa Asp Xaa Val 
1               5       


<210>  71
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is Phg

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa is Orn

<400>  71

Phe Xaa Arg Asp Xaa Thr 
1               5       


<210>  72
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is Phg

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa is Cit

<400>  72

Phe Xaa Lys Asp Xaa Val 
1               5       


<210>  73
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa is Cit

<400>  73

Phe Phe Lys Asp Xaa Thr 
1               5       


<210>  74
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa is Orn

<400>  74

Phe Phe Lys Asp Xaa Thr 
1               5       


<210>  75
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is Phg

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa is Orn

<400>  75

Xaa Phe Lys Asp Xaa Val 
1               5       


<210>  76
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is Phg

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is Phg

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa is Orn

<400>  76

Xaa Phe Xaa Asp Xaa Val 
1               5       


<210>  77
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is Phg

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is Phg

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is Nva

<400>  77

Xaa Phe Xaa Asp Ile Xaa 
1               5       


<210>  78
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is Phg

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is Phg

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is Nle

<400>  78

Xaa Phe Xaa Asp Ile Xaa 
1               5       


<210>  79
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is Phg

<400>  79

Trp Phe Xaa Asp Ile Ile 
1               5       


<210>  80
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is Nva

<400>  80

Trp Phe Trp Asn Ile Xaa 
1               5       


<210>  81
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  81

Trp Phe His Gln Ile Val 
1               5       


<210>  82
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  82

Trp Trp Asn Asp His Val 
1               5       


<210>  83
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  83

Gly Phe Phe Trp Phe His Val 
1               5           


<210>  84
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  84

Phe Phe Trp Phe His Val Ala Val 
1               5               


<210>  85
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  85

Ile Phe Phe Trp Phe His Val Gly 
1               5               


<210>  86
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  86

Ala Gly Phe Phe Trp Phe His Val 
1               5               


<210>  87
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  87

Phe Phe Trp Phe His Val Tyr 
1               5           


<210>  88
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  88

Ala Phe Met Trp Phe His Val 
1               5           


<210>  89
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  89

Phe Met Trp Phe His Val Ala Gly 
1               5               


<210>  90
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  90

Ala Leu Phe Met Trp Phe His Val 
1               5               


<210>  91
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  91

Phe Met Trp Phe His Val Val 
1               5           


<210>  92
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  92

Gly Phe Met Trp Phe His Val Gly 
1               5               


<210>  93
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  93

Ala Phe Phe Trp Asp Ile Val 
1               5           


<210>  94
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  94

Phe Phe Trp Asp Ile Val Gly Gly 
1               5               


<210>  95
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  95

Ile Phe Phe Trp Asp Ile Val Ile 
1               5               


<210>  96
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  96

Thr Gly Phe Phe Trp Asp Ile Val 
1               5               


<210>  97
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  97

Phe Phe Trp Asp Ile Val Tyr 
1               5           


